Multiple sclerosis: High prevalence of the &#8216;central vein&#8217; sign in white matter lesions on susceptibility-weighted images by Sparacia, G. et al.
Original article
Multiple sclerosis: High prevalence of the
‘central vein’ sign in white matter lesions
on susceptibility-weighted images
Gianvincenzo Sparacia1 , Francesco Agnello1, Angelo Gambino1,
Martina Sciortino2 and Massimo Midiri1
Abstract
Purpose: The aim of this study was to determine the occurrence and distribution of the ‘central vein’ sign in white matter
lesions on susceptibility-weighted magnetic resonance images in patients with multiple sclerosis (MS) and cerebral small
vessel disease (CSVD).
Materials and methods: T2-weighted and fluid-attenuated inversion recovery magnetic resonance images of 19 MS patients
and 19 patients affected by CSVD were analysed for the presence and localisation of focal hyperintense white matter lesions.
Lesions were subdivided into periventricular or non-periventricular (juxtacortical, subcortical, deep white matter and
cerebellar) distributed. The number and localisation of lesions presenting with the central vein sign were recorded and
compared between MS and CSVD lesions.
Results: A total of 313 MS patients and 75 CSVD lesions were identified on T2-weighted and fluid-attenuated inversion
recovery magnetic resonance images. The central vein sign was found in 128 MS lesions (40.9%), and the majority of them
(71/128, 55.5%) had a periventricular distribution. The central vein sign was found in 22 out of 75 (29.3%) CSVD lesions, and
periventricular distribution was seen in six out of 22 (27.2%) CSVD lesions. The difference in the proportion of white matter
hyperintense lesions that presented with the central vein sign on susceptibility-weighted images in patients with MS and
CSVD was statistically different, and a significantly higher number of MS patients presented with lesions with the central
vein sign compared to CSVD patients.
Conclusion: The presence of the central vein sign on susceptibility-weighted images for MS lesions improves the under-
standing of the periventricular distribution of MS lesions and could contribute as adjunctive diagnostic criteria for MS
disease.
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Introduction
Multiple sclerosis (MS) is the most common auto-
immune neurological disorder aﬀecting young adults.
It is pathologically characterised by multifocal inﬂam-
mation, demyelination, axonal injury and neuronal
loss.1
Conventional magnetic resonance imaging (MRI)
has high sensitivity in demonstrating MS dissemination
in time and space.1,2 The current diagnosis of MS is
based on a combination of clinical, radiological and
laboratory ﬁndings.2 However, MRI speciﬁcity for the
diagnosis of MS is relatively low because several vascu-
lar, infectious, neoplastic, congenital and metabolic dis-
eases can show a similar radiological appearance and
mimic MS at MRI.3,4 MS is thus usually a diagnosis of
exclusion.
Eﬀorts have been made to improve the ability
of imaging to diﬀerentiate MS from its mimic.
One option may be to detect a small central vein (the
‘central vein’ sign) in MS lesions. Indeed, pathological
studies at autopsy have demonstrated that the typical
extension and morphology of the MS lesions is due to
the perivenous localisation in the white matter of the
brain and spine.5,6 As a result of high sensitivity to slow
venous ﬂow, the utility of susceptibility-weighted
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imaging (SWI) sequence has recently been investigated
for the detection of the central vein sign.7,8
In a small prospective study, Kau et al.7 have
reported that although the central vein sign was not
exclusively present in MS lesions it helps diﬀerentiate
MS from non-MS lesions. More recent studies at ultra-
high-ﬁeld have demonstrated that the presence of a cen-
tral vein improves the diﬀerentiation of MS and
vascular lesions.9–11 In addition, Lane et al.8 have
reported that the detection of the central vein sign
helps diﬀerentiate MS from dementia.
There is also an increasing acceptance of the poten-
tial role of the central vein sign as a biomarker of
inﬂammatory demyelination in the most recent guide-
lines for MS diagnosis.12–15 However, further research
is required to consider the central vein sign a reliable
diagnostic criterion of MS. As the most common diﬀer-
ential diagnosis for MS is focal white matter hyperin-
tensity due to cerebral small vessel disease (CSVD), the
purpose of our study was to compare the occurrence
and distribution of the central vein sign in white matter
lesions among patients with MS and CSVD.
Materials and methods
This retrospective study was approved by the institu-
tional review board of our institution, and informed
consent was waived; however, informed written consent
for the MRI was obtained in all patients.
This study included 19 patients (nine men, 10
women; aged 19–53 years, mean age 36.9 years) with
MS and 19 patients (nine men, 10 women; aged 59–72
years, mean age 61.2 years) with CSVD. All MS
patients underwent brain MRI examination as part of
the routine follow-up. MRI examinations were per-
formed between December 2016 and April 2017.
Inclusion criteria for MS patients were age over 18
years, clinical diagnosis of MS and fulﬁllment of 2010
revised McDonald criteria for MS.2 The mean disease
duration for MS was 8.1 6.5 years. Eleven patients
(57.9%) had the relapsing–remitting clinical subtype,
six (31.5%) had the secondary progressive clinical sub-
type, and two (10.5%) had the primary progressive clin-
ical subtype. The Expanded Disability Status Scale
(EDSS) of the patients with MS ranged between 1
and 4.5, with a mean of 1.9 0.8.
Diagnosis of CSVD required lack of symptoms sug-
gestive of another white matter disease, identiﬁcation of
vascular risk factors, and the presence of cerebral white
matter hyperintensities on T2-weighted and ﬂuid-atte-
nuated inversion recovery (FLAIR) MRI, as commonly
seen in CSVD.
MRI protocol
All MRI examinations were performed on a 1.5 T MR
scanner (Achieva, Philips Medical Systems, Best,
The Netherlands) using an 8-channel phased-array
head coil.
The MRI protocol included axial and sagittal fast-
spin echo T2-weighted sequences (TR/TE, 5100/110);
axial FLAIR sequences (TR/TE/TI, 8000/140/2400);
axial, sagittal and coronal contrast-enhanced
(0.1mmol/kg of gadobutrol; Gadovist, Bayer, Bonn,
Germany) fast-spin echo T1-weighted sequences
(TR/TE, 650/12); ﬁeld-of-view (FOV) 22 cm; matrix
320 320; slice thickness 5mm; intersection gap
1mm; number of excitations 2.
The SWI sequences were obtained using a technique
that combines a long-TE high-resolution fully ﬂow-com-
pensated 3DGRE sequence with ﬁltered phase informa-
tion in each voxel both to enhance the contrast in
magnitude images and add the susceptibility diﬀerences
between tissues as a new source of information.15–18
The SWI images were obtained without the injection
of contrast material (TR/TE, 34/24; ﬂip angle 10; FOV
22 cm; matrix 256 512; slice thickness 1.2mm; no
intersection gap; number of images 140; number of
excitations 1; and acquisition time 5.40minutes).
The SWI images were also post-processed with the min-
imum intensity projection (MinIP) algorithm in the
axial plane with a slice thickness of 3–10mm to visual-
ize better the ‘signal void’ of the vessel structures.
Image evaluation
The T2-weighted and FLAIR images, presented in
random order on a picture archiving and communica-
tion system (Agfa HealthCare GmbH, Bonn,
Germany), were analysed in consensus by two neuror-
adiologists, each with at least 10 years of experience
who were unaware of the patients’ clinical information,
for the presence and localisation of focal hyperintense
white matter lesions.
Lesions were subdivided into periventricular or non-
periventricular distributed. Non-periventricular lesions
were subdivided into juxtacortical, subcortical, deep
white matter and cerebellar. Only white matter lesions
greater than 5mm in largest diameter were considered,
limiting the overall number of lesions greater than
3mm in largest diameter to a maximum of eight.
Conﬂuent lesions were excluded. We chose these inclu-
sion criteria that have been reported better to reﬂect
equivocal cases in clinical routine and better reﬂect
the critical lesion load regarding the Barkhof criteria.7
The SWI images were evaluated for the presence or
absence of a venous structure within the MS lesions. To
better diﬀerentiate the signal void of a vessel, the MinIP
post-processed SWI images were also used. The pres-
ence of a vein within the MS lesion was deﬁned accord-
ing to the standard radiological deﬁnition established in
the North American Imaging in Multiple Sclerosis
(NAIMS) guidelines,15 which recommend that the
vein appears as a thin hypointense line or small hypoin-
tense dot; when technically possible, the vein can be
visualised in at least two perpendicular planes; the
vein runs partially or entirely through the lesion, but
must be located centrally regardless of the lesion’s
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shape; the vein has a small (<2mm) apparent diameter.
As exclusion criteria, the standard radiological deﬁn-
ition was also used: the lesion is less than 3mm in diam-
eter in any plane; the lesion merges with another lesion
(conﬂuent lesion); the lesion has multiple distinct veins;
the lesion is poorly visible (as a result of motion or
other MRI-related artifacts).
Lesions containing calciﬁcation, hemosiderin and
iron accumulation, which mimic venous structures
because they show a hypointense signal similar to
venous structures, were excluded on the basis of the
lack of signal void. Calciﬁcations were excluded with
the ﬁltered phase images.
Statistical analysis
Statistical analysis was performed using a non-para-
metric Wilcoxon rank-sum test to compare the number
of white matter lesions presenting with the central vein
sign on SWI images in MS and CSVD patients, and the
number of MS patients presenting with lesions with the
central vein sign with the number of CSVD patients pre-
senting with lesions with the central vein sign.
Diﬀerences for a P value of less than 0.05 were con-
sidered statistically signiﬁcant. Data are presented as
percentages and mean standard deviations.
The statistical analysis was performed using SPSS
Statistics software (SPSS, Chicago, IL, USA). As the
sample size for this study was small, we assessed the
power of the Wilcoxon rank-sum test with the analysis
software G*Power (Heinrich,Heine,University,
Du¨sseldorf, Germany) to ensure that a statistical
power of 0.90 for the result was achieved.
Results
A total of 313 MS lesions were identiﬁed in MS
patients, while 75 cerebral white matter focal
hyperintense lesions were identiﬁed in CSVD patients.
All lesions were clearly visible both on the T2-weighted
and FLAIR images.
In MS patients, periventricular distribution was
found in 139 (44.4%) lesions while non-periventricular
distribution was found in 174 (55.6%) lesions. The
smallest MS lesion diameter was 3mm. A total of 128
MS lesions containing venous structures (the central
vein sign) were detected out of 313 MS lesions
(40.9%), and the majority of them (71/128, 55.5%)
had a periventricular distribution (Figures 1 and 2).
In CSVD patients, periventricular distribution was
found in 31 (41.3%) lesions while non-periventricular
distribution was found in 44 (58.7%) lesions. The cen-
tral vein sign was found in 22 out of 75 (29.3%) CSVD
lesions and periventricular distribution was seen in six
out of 22 (27.2%) CSVD lesions (Figure 3).
Data are summarised in Table 1.
The diﬀerence in the proportion of white matter
hyperintense lesions that presented with the central
vein sign on SWI images in patients with MS and
CSVD was statistically diﬀerent (P< 0.5). The analysis
of the proportion of lesions with the central vein sign at
patient levels showed that a signiﬁcantly higher number
of MS patients presented with lesions with the central
vein sign compared to CSVD patients, particularly in
periventricular distributed comparison (18 MS patients
vs. 11 CSVD patients, P< 0.5).
Discussion
In this study, we detected the central vein sign more
frequently in patients with MS than in patients with
CSVD. Moreover, the periventricular distribution of
the central vein sign was more evident for periventricu-
lar MS lesions than for periventricular CSVD lesions.
These results reinforce the ﬁndings of previous stu-
dies,9,11–15 and support the potential role of the central
Figure 1. Axial (a) FLAIR MR image shows a T2 hyperintense MS periventricular lesion (arrow). On corresponding (b) SWI image and
(c) magnified SWI image, the central vein sign was identified as a linear signal void indicating a small central vein within the MS lesion
(arrowhead). FLAIR: fluid-attenuated inversion recovery; MR: magnetic resonance; MS: multiple sclerosis; SWI: susceptibility-weighted
imaging.
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vein sign as adjunctive diagnostic criteria for MS as an
imaging biomarker of the disease. Small cerebral veins
within MS plaques were depicted using a SWI contrast
mechanism that exploits tissue magnetic susceptibility
diﬀerences to generate the contrast.15–19 The higher fre-
quency observed in our study of the central vein sign in
MS lesions, compared with CSVD lesions, reﬂects the
diﬀerent mechanism of lesion development.
The observation that most MS lesions showing the
central vein sign had a periventricular distribution
(Figures 1 and 2) reﬂect the fact that the process of
MS starts around small cerebral veins, as demonstrated
by pathology and immunocytochemistry. The perivas-
cular space surrounding these veins is thought to be a
privileged site for immune cells to interact with antigen-
presenting cells, which can then trigger an inﬂamma-
tory cascade leading to the formation of lesions around
the veins.15,19
To better diﬀerentiate the central veins from their
mimickers, such as microbleeds and calciﬁcation,
MinIP reformatted SWI images are valuable in demon-
strating the continuity of the central veins along their
course.20 The central vein sign, however, can be found
in other neurological diseases such CSVD and
migraine.21–23 While Lummel et al.24 have reported
that the central vein sign was equally present in MS
and CSVD lesions, multiple recent studies at ultra-
high-ﬁeld have reported a signiﬁcantly lower propor-
tion (45% at most) of vasocentric white matter
lesions in CSVD, thus supporting the hypothesis that
the presence of a central vein improves diﬀerentiation
of MS and vascular lesions.9,10,23
As small veins are ubiquitous and may traverse any
type of white matter lesion coincidentally, the deﬁnition
of the central vein sign should be reﬁned by considering
target lesions greater than 5mm in the largest diameter
Figure 2. Axial (a) FLAIR MR image shows a T2 hyperintense periventricular MS lesion (arrow). On corresponding (b) SWI image and (c)
magnified SWI image, the central vein sign was identified as a central punctate vein showing a signal void within the MS lesion
(arrowhead). FLAIR: fluid-attenuated inversion recovery; MR: magnetic resonance; MS: multiple sclerosis; SWI: susceptibility-weighted
imaging.
Figure 3. Axial (a) FLAIR MR image shows a T2 hyperintense periventricular CSVD lesion (arrow). On corresponding (b) SWI image and
(c) magnified SWI image, the central vein sign was identified as a central punctate vein showing a signal void within the CSVD lesion
(arrowhead). FLAIR: fluid-attenuated inversion recovery; MR: magnetic resonance; CSVD: cerebral small vessel disease; SWI: suscept-
ibility-weighted imaging.
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and limiting the overall number of white matter lesions
greater than 3mm to a maximum of eight, which is a
critical lesion load regarding the Barkhof criteria for
the diagnosis of MS.7
Kau et al.,7 using this reﬁned criteria, reported the
very high power of discrimination of the central vein
sign on SWI images for diﬀerentiation between white
matter lesions associated with MS and to non-MS dis-
ease. The relatively low percentage of the central vein
sign inMS lesions reported in this study could be related
to higher ﬁeld strength or the use of diﬀerent sequences
(e.g. FLAIR* sequences) used in other studies.9–11,22–24
Maggi et al.25 reported that SWI images obtained after
contrast media administration improved the contrast
between the hypointense central vein and the surround-
ing hyperintense MS lesion. This aspect requires further
validation in a large series of patient populations and
could be considered in our future research.
The main limitation of this study was that the
patient population was small, thus our results should
be conﬁrmed in large series. Another limitation was
that the study design was retrospective; however, we
selected all consecutive patients with MS. Finally,
there is a signiﬁcant diﬀerence in age between the MS
and CSVD patients, which reﬂects the diﬀerent age dis-
tribution of these two diseases.
Conclusion
In conclusion, our study, using the SWI sequence with-
out contrast media administration, demonstrated the
presence of the central vein sign in 40.9% of MS
lesions, most of them periventricular distributed
(55.5%), while the central vein sign was found in
29.3% of CSVD lesions with only 27.2% of periven-
tricular distributed CSVD lesions.
The diﬀerence in the proportion of white matter
lesions that presented with the central vein sign on
SWI images in patients with MS and CSVD was stat-
istically signiﬁcant, and a signiﬁcantly higher number of
MS patients presented with lesions with the central vein
sign compared to CSVD patients, particularly in peri-
ventricular distributed comparison. This ﬁnding
improves the understanding of the periventricular dis-
tribution of MS lesions and could contribute as
adjunctive diagnostic criteria for MS disease.
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